ebm medical tirzepatide The standard 2.5 mg starting dose of may be too high for some people. Some clinicians use lower customized doses in sensitive patients to reduce nausea, fatigue and excessive appetite suppression PDF) EBM BLS: Tirzepatide Helps

Up to 25% body weight loss The SURMOUNT clinical trials demonstrated that tirzepatide therapy not only improved glucose levels but also had a substantial impact on body weight reduction

Primary endpoint of ACHIEVE Secondary endpoint of ACHIEVE for weight loss There were many other new GLP-1 family of drugs and combinations presented without publications in NEJM or The Lancet or are in development

Clinical trials (SUSTAIN-6) have shown cardiovascular benefits with semaglutide, though this is not a specific licensed indication in the UK

Promotes Gentle Exfoliation for Smoother Skin: Alpha Hydroxy Acids (AHAs) in the formulation helps remove the uppermost layer of dead skin